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Abstract
Bioreactors are systems that can be used to monitor the response of tissues and cells to candidate drugs. Building on the experience
developed in the creation of an osteochondral bioreactor, we have designed a new 3D printed system,which allows optical access to the
cells throughout testing for in linemonitoring. Because of the use of 3D printing, the fluidics could be developed in the third dimension,
thus maintaining the footprint of a single well of a typical 96 well plate. This new design was optimized to achieve the maximum fluid
transport through the central chamber, which corresponds to optimal nutrient or drug exposure. This optimization was achieved by
altering each dimension of the bioreactor fluid path. A physical model for optimized drug exposure was then created and tested.







After initial screening on plated cells, assessment of new can-
didate pharmaceuticals primarily relies on animal and human
testing; however, organoid models are being developed as a
very relevant, complementary option as they can be employed
for the medium to high throughput screening of drug candi-
dates prior to costly animal or even human testing (Demircak
and Arslan Yildiz n.d.; Sutherland et al. 2013). Furthermore,
these in vitro microphysiological models (Wikswo 2014) are
useful tools to dissect molecular pathways to identify disease
mechanisms. However, their microfluidics are frequently
constrained to one plane because of current manufacturing
constraints, and this limits cell construct architecture to an
environment that might not fully represent the complexity of
native tissues, leading to inaccurate results (Neuži et al. 2012).
3D printing may help to overcome this limitation allowing for
the creation of complex bioreactor geometries where more
biomimetic tissue architectures can be hosted and media can
move in three dimensions rather than merely two (Alexander
et al. 2014). Thus, by increasing the complexity of the fluidics,
more ways of directing cell exposure to candidate drugs are
accessible. Additionally, tissue responses more representative
of in vivo conditions (Bhattacharjee et al. 2016) prior or in
parallel to animal testing can be utilized in order to decrease
the need of animal use and improve the safety profile of the
screened candidate drugs (Wikswo 2014). In fact, animal
physiology is different than that of humans, which in itself
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already limits the predictive power of animal tests. Therefore,
the use of human cells in a 3D environment that models hu-
man tissues could provide more physiologically relevant in-
formation of the effects of candidate drugs on human physi-
ology before clinical trials (McManus 2013). Moreover, mul-
tiple Btissues^ can be connected to study the effects of a drug
on the target tissue but also verify possible side effects
(Iannetti et al. 2016). Appropriate bioreactors for this purpose
are then necessary, i.e., apparatuses in which to place and
maintain native tissues or cells in a 3D scaffold environment
whose response to a candidate drug can be monitored.
In recent work, we have demonstrated how a bioreactor
could be created to generate engineered biphasic osteochondral
(OC) constructs comparable in size to native tissues and to
culture native tissue over several weeks (Fig. 1a‑c)
(Alexander et al. 2014; Iannetti et al. 2016; Lin et al. 2014).
The middle cylinder of this bioreactor is where the cells under
test are hosted in a scaffold, such as a porous polymer or a
permeable hydrogel of methacrylated gelatin (GelMA).
This system was aimed at studying musculoskeletal diseases
such as osteoarthritis (OA), which is characterized by the break-
down of cartilage lining the ends of long bones and currently has
no cure (Lozito et al. 2013). When studying the mechanism of
OA progression to identify possible therapies, it is crucial to
consider both bone and cartilage simultaneously as there is grow-
ing evidence suggesting interplay between them (Alexander et al.
2014; Goldring and Goldring 2016; Lozito et al. 2013). While
effective and innovative, the current OCmicrophysiological sys-
tem relies on end point testing, rather than periodic and non-
destructive assessment (Iannetti et al. 2016).
To grant optical access through the construct for continu-
ous monitoring, the current bioreactor (Fig. 1a-c) has been
modified by adding a glass coverslip over the 3D construct.
For this purpose, the height of the chamber must beminimized
to a height conducive to optical sectioning, and optical imag-
ing tools such as fluorescently labeled cells or cells transfected
with gene reporters must be employed (Grande and Bonfig
2015). This new system (Fig. 1d) is essentially a cross section
of the previous bioreactor fluid path (Fig. 1c), which can be
used for continuous optical monitoring.
A limitation of simply taking the cross section of the pre-
vious system, however, is that fluid flow through the central
chamber is limited. Most of the media flows around the ring
without ever making contact with the test cells in the middle.
Indeed, resistance to flow through the central chamber is very
high because of the relatively low permeability of the trans-
parent hydrogel that would be used (such as GelMA). Thus, to
change the fluid path and increase nutrients/drug exposure in
the central chamber (Hsu et al. 2013a; Saleh 2002), we created
an improved bioreactor model by 3D printing. First, we tested
and optimized the internal fluid path via computational fluid
dynamics (CFD) with the ANSYS CFX commercial software.
After developing a computationally guided analysis protocol,
we set up an optimization procedure of the bioreactor design
parameters within our experimental constraints. Finally, we
compared the performance of the optimal shape against the
simple ring model, detecting significant improvements that
were confirmed experimentally with 3D printed bioreactors
models.
2 Methods
2.1 Designing the flow path
Models of the flow path were created using the CAD software
SOLIDWORKS 2016 (Waltham, MA). The design con-
straints of the bioreactor were the following: (i) the volume
of the central chamber must be roughly 10 μL; (ii) the height
of the central chamber must not limit optical sectioning via
imaging; (iii) the overall dimensions must allow for the design
to fit into a 96-well plate unit well. To allow for optical sec-
tioning via a confocal microscopy, the height of the cell hous-
ing was kept to 1 mm (Grande and Bonfig 2015) consequently
requiring the diameter of the central chamber to be 3.6 mm for
a volume of ~10 μL. Hence, to fit into a 96-well plate, the
surrounding ring must be no larger than 6.86 mm in diameter.
Given those design constraints, the other parameters varied
within an optimization procedure were: (A) the diameter of
the surrounding channel, (B) the step height, (C) the outer ring
diameter, (D) the pore diameter, and (E) the number of pores
(see Fig. 3 for a visualization of these). These features were
changed independently to observe how each affected the flow
in the entire model. Designs were saved in SOLIDWORKS as
IGES files that were passed to the CFD analysis software
described in the next section.
2.2 Computational fluid dynamics modelling
The CFD analysis software ANSYS Fluid Flow (CFX) v. 15.0
(Canonsburg, PA) was used for all simulations. The simula-
tion setup was similar the one previously developed by our
research team (Iannetti et al. 2016), in which a dual fluidic
bioreactor was used for high throughput screening. The IGES
geometry files were imported into the project, and the cham-
ber hosting the cells (central chamber) was represented as a
porous domain, conferring it the properties of a permeable
solid that permits fluid flow. Two different hydrogels were
used in the simulations: a photocrosslinked methacrylated gel-
atin (GelMA) and agarose, the properties of each are reported
in Table 1 (Johnson and Deen 1996; Taffetani et al. 2014).
A volume flow rate of 1 mL/day was imposed at the
inlet, and the outlet was open to the environment. Steady
state velocities through the central chamber resulting from
the ANSYS simulation were measured in CFX Post and
plotted against each specific change in the bioreactor
 18 Page 2 of 7 Biomed Microdevices  (2018) 20:18 
geometry to determine the relationships between design
features and central velocity. The assessment of each
model was based on the velocity of the fluid through the
middle of the central chamber, which gives a representa-
tion of nutrients/drug exposure.
A transient simulation was also set up in which the central
chamber was filled with the porous material while the remain-
ing bioreactor and chamber were filled with air. The simula-
tion was then run with fluid starting from the inlet to see how
the central chamber initially reacts to the onset of flow and to
observe how long it takes for the porous central chamber to
reach steady-state conditions.
2.3 3D printing
The bioreactor was printed by stereolithography (SLA) using
a 3Dsystems Viper si2 (Rock Hill, SC) printer and Somos
WaterShed XC 11122 (Elgin, IL) resin. The resolution of the
printer is 50 μm and the smallest possible printable void is
600 μm.
2.4 Fluidic validation
Agarose (2-Hydroxyethylagarose Type VII, low gelling tem-
perature, Sigma-Aldrich) was mixed with water at a concen-
tration of 2% w/v and heated on a hot plate until transparent to
ensure full dissolution. The hot agarose solutionwas poured in
a mold and allowed to rapidly cool to gel. Methacrylated gel-
atin (GelMA) was prepared as previously described (Lin et al.
2014). Briefly, dry GelMA powder was resuspended in PBS,
mixed with the previously described LAP (photoinitiatior)
(Lin et al. 2014) at a final concentration of 10% GelMA and
0.15% LAP. This solution was poured into a mold and cured
for 1.5 min using an UV light with wavelength of 390–
395 nm.
Once the bioreactor was printed and assembled, the
central chamber was filled with the GelMA or agarose
scaffold. The inlet was connected to a syringe filled with
water placed in a Kiyatec FC230 (Greenville, SC) pump
which forced the water through the bioreactor at a rate of
1 mL/day. Food coloring was added to the water in order
to better observe the flow through the central chamber.
Fig. 1 a Array of four bioreactors CAD models (Iannetti et al. 2016), (b) corresponding cross-section (Iannetti et al. 2016), (c) the fluid path (i.e.
negative) of the current single bioreactor, (d) modified configuration of the bioreactor
Table 1 Properties of the material
residing in the central chamber
(Johnson and Deen 1996;
Taffetani et al. 2014)
Material Porosity Permeability (m2) Molar Mass (kg/kmol) Density (kg/m3)
GelMA 0.8 1*10−16 1.00117 1190
Agarose 0.985 6.16*10−16 630.549 1026
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Pictures were then taken at 15-min intervals to observe
the flow of the fluid through the bioreactor.
3 Results
3.1 Bioreactor design
The main constraint for the new bioreactor design was to
create a prototype that granted optical access to the cells
throughout the central chamber for the duration of the exper-
iment. In order to allow for optical access to the cells, the
thickness of the cell construct could not exceed 1mm in height
as this is the typical range of the maximum image sectioning
depth of a standard confocal microscope with a 10× objective
(Grande and Bonfig 2015). The main block of the bioreactor
(Fig. 2a) contains the fluidics feeding the central chamber
(Fig. 2b) that is sealed with a removable base and lid with a
coverslip (Fig. 2c-d).
In the bioreactor design, before shape optimization (Fig. 1c),
cells were hosted in the central chamber within a thick scaffold,
which did not allow optical access to most of the construct
volume (Lozito et al. 2013). The specific goal for this research
was to define the optimal fluidic design of an individual biore-
actor chamber, such as the one seen in Fig. 2b, that allows
complete permeation of the engineered constructs with nutri-
ents and other soluble factors. The flow was controlled by
changing the channel’s geometry to tune local pressure
differences, and the effectiveness of each design option was
quantified measuring the velocity of the fluid through the cen-
tral chamber. In fact, since the flow rate at the inlet is fixed, the
higher the velocity through the central chamber, the greater the
total amount of mass transport and consequent drug and nutri-
ent exposure for the cells over time.
3.2 Design optimization
Optimization of the bioreactor to control the flow through the
inner chamber has been achieved by altering the dimensions
of the features reported in Fig. 3.
Each dimension has been progressively increased in
0.05 mm increments while all other dimensions were kept
constant, and the flow velocity in the central chamber has been
plotted against the respective dimension cumulative incre-
ments (Fig. 4). A line plot was used so that local changes in
the velocity from one configuration to the next can be visual-
ized. Furthermore, the dashed line represents the regression of
the data obtained by a simple exponential y = a*exp.(bx). The
exponent b can be seen as an indicator of the sensitivity of the
central velocity with respect to the geometric parameter being
changed, while a is just a scaling constant. The values for b are
−7.565 for channel diameter, 0.5387 for step height, 0.06268
for outer ring diameter, 0.9462 for pore diameter, and 0.1412
for the number of pores. The higher the exponent, the more
sensitive the velocity from the corresponding input parameter.
Fig. 2 a Bioreactor, (b) volume occupied by fluid and constructs, (c) assembled bioreactor model, (d) exploded view
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When plotted on a log scale, fluid velocity is directly
dependent on the step height, outer ring diameter, pore
diameter, and number of pores whereas the correlation
with the channel diameter is inversely dependent. Once
parameter constraints are defined, it is possible to identify
the maximum flux through the central chamber hosting
the engineered constructs simply using these empirical
relationships for each design feature.
3.3 Design optimization
The step height can be extended only a certain amount before
it runs into other portions of the model; therefore, the maxi-
mum size for the step height is 1.75 mm. To eventually be
used in a 96-well plate, the entire ring of the design must fit
within a 6.8 mm diameter circle. The pore diameter can only
be as large as the channel diameter, and, because the
magnitude of the exponential term b (our indicator of sensi-
tivity) is much larger for the channel diameter relationships
than that of the pore diameter, it was determined that the mod-
el benefits more from a small channel than large pores. To
satisfy these requirements and taking the 3D printing capabil-
ities into account, the optimal dimensions were determined
and are reported in Fig. 3.
3.4 Design comparison
Taking advantage of the possibility offered by 3D printing to
exploit the third dimension to develop the fluidic path, an
optimized bioreactor design was created, and its steady-state
ANSYS fluid flow results were compared to a simple circular
ring model to determine how much the design optimization
improved mass transport. The steady-state simulation results
produced a central velocity of 5.026e-13 m/s for the ring
Fig. 3 Defining the features of
the bioreactor
Fig. 4 Plots of the central velocity versus various dimensions of features in Fig. 3
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model and 1.409e-12 m/s for the step model, with an almost
three hundred percent increase for the latter.
Much more computationally demanding transient simula-
tions were also performed, starting with the central chamber
filled with a porous medium while the rest of the bioreactor
was filled with air. The results show that the central chamber
reaches steady-state conditions upon the fluids first pass
around the surrounding channel. This takes ~2000 s for the
simple ring model compared to ~3000 s for the step model;
however, this time increase takes place simply because the
step model has a longer path to travel until the flow moves
completely around the surrounding channel to the outlet. For
the simulation with the central chamber filled with agarose,
the mass flow rate across a transverse plane placed at the
midpoint of the chamber was measured. For the ring model,
the mass flow was 4.640e-16 kg/s while the step model
facilitated a mass flow of 1.099e-15 kg/s through the central
chamber. Thus, at steady-state the step model produced a net
mass flow rate 237% that of the ring model. This greater mass
flux outweighs the fact that the stepmodel chamber takes 50%
longer to reach steady state as the volume flowing through the
central chamber is 2.37 times greater.
These twomodels were 3D printed and tested experimentally
by flowing dyedwater through the systems at a rate of 1mL/day
andmaking observations every 15min (Fig. 5). The results from
the laboratory tests confirm the simulation results. It is apparent
that the step bioreactor achieves more nutrients/drug exposure
than the ring bioreactor as evidenced by more volume of dye
flowing through the central chamber over the same time period.
4 Discussion
As shown in the previous section, the flux through the central
chamber can be controlled by simply altering the geometry of
the device. Experimental data corresponding to the simula-
tions confirmed that, by using the ANSYS simulations as a
guide, the design could be optimized to significantly increase
the flux through the central chamber while still leaving an exit
path for any air bubbles. The results indicate that maximiza-
tion of fluid velocity, and therefore the total nutrients/drug
exposure, can be achieved by minimizing the channel diame-
ter and maximizing all other design features; therefore, the
sole constraints are determined by the resolution of the 3D
printer and by the overall design considerations of the model.
With this optimized bioreactor, the central chamber was filled
with either GelMA or agarose, each of which affects the re-
sults differently because of their different permeabilities. In
particular, 2% agarose had a higher permeability than
GelMA, which in turn allows greater nutrients/drug exposure
of the cells. Furthermore, the transient simulations show that
both configurations have reached steady-state approximately
around the 45-min image as shown experimentally in Fig. 5.
Consequently, at this time, the fluid is flowing through the
central chamber at its maximum speed, which confirms the
greater effectiveness for the optimized design bioreactor.
The method of increasing the path length to increase drug
exposure was seen in work by Hsu et al. (Hsu et al. 2013b);
however, this work only exploits fluidics in two dimensions
which greatly increases the bioreactor footprint and makes the
Fig. 5 Results from laboratory testing proving that the step model attains
more drug exposure through the central chamber
Fig. 6 a Dual inlet bioreactor, (b)
asymmetric bioreactor
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method impractical when utilizing a 96-well plate format. With
the use of 3D printing, this extra pathlength can be moved to the
third dimension which increases the pathlength without chang-
ing the footprint. This increased pathlength effectively increases
the system’s hydraulic resistance of the surrounding channel,
thus leading to more fluid to flow through the central chamber
whose resistance does not change. Higher hydraulic resistance
could also in principle be achieved by decreasing the channel
diameter (Idel’chik 1966; Saleh 2002), however this option is
currently limited by the resolution of the 3D printer. Hydraulic
resistance plays a key role in microfluidics as the small channel
diameters produce a large impact on the resistance of the fluid
path. The effect of hydraulic resistance has been for instance
explored in the experimental study on flow-resistance law for
small diameter plastic pipes (Bagarello et al. 1995) which agrees
well with our results. Better control on 3D printing resolution at
the micrometer scale could then greatly benefit the development
of 3D printed microfluidic systems with reduced footprint.
A major limitation in this study arises from the fact that
devices were printed close to the printer’s tolerances. The
resulting fluid path, although designed as perfectly circular,
likely has a rough step profile at such a small scale, and this
imperfection might affect the flow in a way that is not entirely
known. Mitigating this uncontrolled effect, both circular and
step bioreactor design are likely to be similarly affected, thus
the relative difference observed in the experimental outcomes
should be reliable and confirm the differences between the
models’ findings.
Having confirmed the predictive value of the simulations,
different and unique models can be created and tested in
ANSYS to account for specific experimental needs in engi-
neering multi-phase and multi-component constructs or for
delivering drug candidates to specific construct locations.
For instance, a dual inlet model (Fig. 6a) can be used to engi-
neer bone on one side of the central chamber with cartilage on
the other. Similarly, a compound could be delivered to only
one tissue to study cartilage-bone interaction, when only one
of the two is subject to a stress signal or to a drug.
Alternatively, an asymmetric, single-inlet bioreactor (Fig.
6b) can be designed to test two different drug exposures si-
multaneously. This can be accomplished by changing the
number of pores on the two sides of the bioreactor or by
changing the distribution of the GelMA or agarose in the
central chamber. By utilizing two different concentrations in
differing configurations, differing drug exposures can be
achieved in different areas of the 3D construct.
5 Conclusions
A computationally-guided bioreactor was successfully de-
signed to increase perfusion of cells in a construct. As predict-
ed by the simulations and confirmed experimentally,
compared to the circular ring model, the optimized step bio-
reactor achieves 2.37 times greater flux through the central
chamber. The optimized bioreactor has multiple advantages:
(1) it maximizes nutrients/drug exposure to the cells under
test, (2) it minimizes the dimensions of the model, (3) it allows
for optical access within the 3D construct, and (4) it maintains
dimensions compatible with a standard 96-well plate.
With the optimization procedure validated, different and
more complex bioreactor configurations can be created. For
instance, true OC tests can be conducted on both bone and
cartilage simultaneously by utilizing the dual inlet bioreactor
introduced in section 4. An array of bioreactors can also be
simulated to study how the pressure-drop changes through
each subsequent model. Based on these studies, a bioreactor
comprised of an array of identical units as the ones described
above, is currently being implemented to allow for medium to
high throughput in vitro drug screening.
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